Lewis H. Bender - Dissemin

All papers authored by Lewis H. Bender

This paper is made freely available by the publisher.

2020 Lewis H. Bender

, Franco Abbate, Ian B. Walters

Intratumoral Administration of a Novel Cytotoxic Formulation with Strong Tissue Dispersive Properties Regresses Tumor Growth and Elicits Systemic Adaptive Immunity in In Vivo Models

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Jacob Stephen Thomas, Anthony B. El-Khoueiry, Ian B. Walters, Nilofer Saba Azad, Lewis H. Bender

, Diana L. Hanna, Giles Francis Whalen, Anthony J. Olszanski, Lillian L. Siu

Pharmacodynamic, safety, and efficacy results of a phase I/II trial of intratumoral INT230-6 alone (IT-01) or in combination with pembrolizumab (PEM) (Keynote A10) in patients with advanced solid tumors.

Upload

2019 Anja C. Bloom, Lewis H. Bender

, Shweta Tiwary, Lise Pasquet, Katharine Clark, Tianbo Jiang, Zheng Xia, Aizea Morales-Kastresana

, Jennifer C. Jones

, Ian Walters, Masaki Terabe, Jay A. Berzofsky

Intratumorally delivered formulation, INT230-6, containing potent anticancer agents induces protective T cell immunity and memory

Upload

Anthony B. El-Khoueiry, Jacob Stephen Thomas, Diana L. Hanna, Lillian L. Siu, Nilofer Saba Azad, Giles Francis Whalen, Lewis H. Bender

, Ian B. Walters, Anthony J. Olszanski

Safety profile of INT230-6, a novel intratumoral (IT) formulation, during injections into a variety of refractory deep and superficial tumors with evidence of tumor regression and immune activation.

Upload

2018 Yada Kanjanapan, Nilofer Saba Azad, Lillian L. Siu, Anthony J. Olszanski, Ian B. Walters, Lisa Kamen, Lewis H. Bender

, Anthony B. El-Khoueiry

Phase 1/2 trial evaluating intratumoral administration of INT230-6 alone and in combination with an anti-PD1 antibody for advanced malignancies.

Upload

2017 Anja C. Bloom, Lewis H. Bender

, Ian B. Walters, Katharine T. Clark, Masaki Terabe, Jay A. Berzofsky

Abstract 5660: Tumor cell death caused by INT230-6 induces protective T cell immunity

Upload

2016 Ian B. Walters, Anja C. Bloom, Lewis H. Bender

, Masaki Terabe, Jay A. Berzofsky

Abstract 4007: A novel immunotherapy, INT230-6, is able to induce high rates of complete response in mice through a cytotoxic T-cell-dependent mechanism

Upload

2015 Anja C. Bloom, Lewis H. Bender

, Masaki Terabe, Jay A. Berzofsky, Ian B. Walters

INT230-6 shows strong synergy with anti-PD-1 and can induce high complete response rates with T cell memory response in a colon cancer mouse model

Download from dx.doi.org

Ian B. Walters, Lewis H. Bender

, Masaki Terabe, Jay A. Berzofsky

Abstract 4295: INT230-6, a novel intratumoral anticancer agent, is able to eradicate large established tumors and stimulate potent anti tumor immunity

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2007 Thomas Julian, Shingai Majuru, Moses Oyewumi, Steven Novick, Miriam Mangelus, Bob Brown, Bharat Mehta, Raymond P. Warrell, Lewis H. Bender

Phase 1 Assessment of an Orally Bioavailable Formulation of Gallium Nitrate (G4544).

Upload

This paper is available in a repository.

Shaker A. Mousa, Ahmad Aljada, Seema Chaturvedi, Fuming Zhang, Haifeng Zhang, Majde Takieddin, Lianli Chi, Ehud Arbit, M. Cristina Castelli, Lewis Bender

, M. Cristina Castelli, Kristen Friedman, Michael M. Goldberg, Robert J. Linhardt

Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects

Download from www.ncbi.nlm.nih.gov

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Lewis H. Bender